Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eszopiclone for Improving Sleep Continuity in MS Patients With Sleep Disturbances and Its Impact on Daytime Fatigue

NCT00594087 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.

NCT NCT00594087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00594087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eszopiclone for Improving Sleep Continuity in MS Patients With Sleep Disturbances and Its Impact on Daytime Fatigue
Lead sponsor
University of Vermont
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2006
Completion date
June 30, 2008
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, relapsing remitting multiple sclerosis, sleep initiation and maintenance disorders